1-8 of 8
Timothy Farren
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Autocrine IL6/STAT3 Signaling Enhances Survival of Chronic Lymphocytic Leukaemia Cells

Fengting Liu, MD, PhD, Li Jia, MD, PhD, Timothy Farren, BSc(HONS), MIBMS, John G. Gribben, MD, DSc, Samir Agrawal, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3598.
https://doi.org/10.1182/blood.V116.21.3598.3598
Published: 2010
Journal Articles

Inter-Laboratory Assessment of Minimal Residual Disease In Chronic Lymphocytic Leukemia – Evaluation of the Novel CD160FCA Assay

Timothy Farren, BSc(HONS), MIBMS, Fengting Liu, MD, PhD, Claire Stephens, MSc, Marion Macey, PhD, FRCPath, Michael Jenner, MD, PhD, FRCPath, Archie Prentice, MB, FRCP, FRCPath, Amit Nathwani, MBChB, FRCP, FRCPath, Samir Agrawal, MD, PhD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 2723.
https://doi.org/10.1182/blood.V116.21.2723.2723
Published: 2010
Journal Articles

CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia

Feng-Ting Liu, Jerome Giustiniani, Timothy Farren, Li Jia, Armand Bensussan, John G. Gribben, Samir G. Agrawal
Journal: Blood
Blood (2010) 115 (15): 3079–3088.
https://doi.org/10.1182/blood-2009-08-239483
Published: 2010
Includes: Supplemental data
Journal Articles

Expression of Surface IgG Is High in Chronic Lymphocytic Leukaemia, and Co-Expression with IgM Confers a Worse Prognosis.

Tom Butler, MBChB, FRCPath, Catherine Wiseman, BSc(Hons), MPhil, Timothy Farren, BSc(HONS), MIBMS, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4371.
https://doi.org/10.1182/blood.V114.22.4371.4371
Published: 2009
Journal Articles

Spontaneous in Vitro Death of CLL Cells Can Be Prevented by Mitochondrial Stabilization Via CD160 Signaling.

Feng-Ting Liu, MB, PhD, Li Jia, MB, PhD, Timothy Farren, BSc(HONS), MIBMS, Jerome Giustiniani, Armand Bensussan, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4372.
https://doi.org/10.1182/blood.V114.22.4372.4372
Published: 2009
Journal Articles

Assessment of Clinical Risk Factors for Symptomatic Venous Thromboembolism in Common Cancers: A VERITY Registry Study

Shankaranarayana Paneesha, MD, Aidan McManus, PhD, Roopen Arya, MBBS, PhD, Nicholas Scriven, MB, Tim Nokes, MD, Timothy Farren, BSc, Sue Bacon, SRN, Anthea Nieland, SRN, Denise O’Shaughnessy, MD, PhD, Peter Rose, MD
Journal: Blood
Blood (2008) 112 (11): 3826.
https://doi.org/10.1182/blood.V112.11.3826.3826
Published: 2008
Journal Articles

CLL Cell Proliferation and IL-6 Production Are Regulated by CD160 - MHC Class I Interactions Offering New Therapeutic Targets.

Jerome Giustiniani, PhD, Catherine Wiseman, BSc, Timothy Farren, BSc, John G. Gribben, MD, PhD, Samir G. Agrawal, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1126.
https://doi.org/10.1182/blood.V110.11.1126.1126
Published: 2007
Journal Articles

Using CD160 as a Novel Approach to the Assessment of Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukaemia (CLL).

Timothy Farren, BSc (Hons), Jerome Giustiniani, PhD, Ulrika Johansson, PhD, Christina Lim, RN, Gemma Athorn, MSc, Adrian Newland, MD, Marion Macey, PhD, Samir Agrawal, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2036.
https://doi.org/10.1182/blood.V110.11.2036.2036
Published: 2007